These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7284824)

  • 1. Differential effects of DL-propranolol on norepinephrine in cerebrospinal fluid and plasma.
    Lerner P; Major LF; Dendel PS; Ziegler MG
    Brain Res; 1981 Nov; 223(2):444-7. PubMed ID: 7284824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.
    Tackett RL; Webb JG; Privitera PJ
    Science; 1981 Aug; 213(4510):911-3. PubMed ID: 7256285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site and mechanism of the centrally mediated hypotensive action of propranolol.
    Tackett RL; Webb JG; Privitera PJ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):66-70. PubMed ID: 4045728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and norepinephrine spillover during propranolol infusion in humans.
    Best JD; Halter JB
    Am J Physiol; 1985 Apr; 248(4 Pt 2):R400-6. PubMed ID: 3985181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid norepinephrine levels in essential hypertension: effects of drug treatment and withdrawal.
    Cubeddu LX; Hoffman IS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S205-10. PubMed ID: 2455180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans.
    Peskind ER; Veith RC; Dorsa DM; Gumbrecht G; Raskind MA
    Neuroendocrinology; 1989 Sep; 50(3):286-91. PubMed ID: 2552342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade decreases norepinephrine release in humans.
    Rosen SG; Supiano MA; Perry TJ; Linares OA; Hogikyan RV; Smith MJ; Halter JB
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E999-1005. PubMed ID: 2163203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-beta-hydroxylase in cerebrospinal fluid and plasma: effects of alpha-adrenergic agents.
    Lerner P; Dendel PS; Major LF
    Brain Res; 1980 May; 189(1):183-91. PubMed ID: 7363084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
    Privitera PJ; Granata AR; Underwood MD; Gaffney TE; Reis DJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):529-33. PubMed ID: 3404445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acid mobilization in rats following intracerebroventricular norepinephrine.
    Barbosa MC; Migliorini RH
    Am J Physiol; 1982 Apr; 242(4):E248-52. PubMed ID: 7065239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insulin-induced hypoglycemia on plasma and cerebrospinal fluid levels of ir-beta-endorphins, ACTH, cortisol, norepinephrine, insulin and glucose in the conscious dog.
    Radosevich PM; Lacy DB; Brown LL; Williams PE; Abumrad NN
    Brain Res; 1988 Aug; 458(2):325-38. PubMed ID: 2850080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.
    Scheinin M; van Kammen DP; Ninan PT; Linnoila M
    Clin Pharmacol Ther; 1984 Jul; 36(1):33-9. PubMed ID: 6203678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adrenergic neurone blockade in the hypotensive action of propranolol.
    Eliash S; Weinstock M
    Br J Pharmacol; 1971 Oct; 43(2):287-94. PubMed ID: 4400571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low- and high-intensity exercise on plasma and cerebrospinal fluid levels of ir-beta-endorphin, ACTH, cortisol, norepinephrine and glucose in the conscious dog.
    Radosevich PM; Nash JA; Lacy DB; O'Donovan C; Williams PE; Abumrad NN
    Brain Res; 1989 Sep; 498(1):89-98. PubMed ID: 2551459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis.
    Bendtsen F; Christensen NJ; Sørensen TI; Henriksen JH
    Hepatology; 1991 Aug; 14(2):237-43. PubMed ID: 1860681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral sympathectomy and adrenal medullectomy do not alter cerebrospinal fluid norepinephrine.
    Peskind ER; Raskind MA; Wilkinson CW; Flatness DE; Halter JB
    Brain Res; 1986 Mar; 367(1-2):258-64. PubMed ID: 3697700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on plasma norepinephrine during sodium nitroprusside-induced hypotension.
    Dean CR; Maling T; Dargie HJ; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1980 Feb; 27(2):156-64. PubMed ID: 7353333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.
    Danuser H; Bemis K; Thor KB
    J Pharmacol Exp Ther; 1995 Aug; 274(2):820-5. PubMed ID: 7636745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injections of beta-noradrenergic substances in the cerebellar anterior vermis of cats affect adaptation of the vestibulospinal reflex gain.
    Pompeiano O; Manzoni D; d'Ascanio P; Andre P
    Arch Ital Biol; 1994 Jul; 132(3):117-45. PubMed ID: 7979861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.